期刊文献+

化疗相关性腹泻的治疗与护理 被引量:7

Chemotherapy treatment and nursing care of diarrhea of relevance
暂未订购
导出
摘要 目的探讨临床治疗与护理干预对化疗相关性腹泻患者的临床疗效。方法回顾性分析河北省迁西县人民医院2008年1月-2010年12月收治入院的采用化疗后出现相关性腹泻的结直肠癌和胃癌住院138例患者的临床资料,所有患者均给予积极治疗和护理干预,评价患者在治疗前后进行卡氏行为状态评分。结果本研究中患者全部抢救成功。患者治疗后卡氏行为状态评分明显改善,与治疗前比较差异有统计学意义(P<0.05)。经积极治疗与护理,138例患者完全停止腹泻,避了免并发症的发生。结论通过对化疗相关性腹泻患者采取有针对性积极治疗和护理干预,提高了化疗致腹泻的治疗效果和患者的生活质量。 Objective To study the clinical treatment and nursing intervention on the clinical curative effect of chemotherapy associated diarrhea patients.Methods The clinical data of 138 hospitalized patients with colorectal can cer and stomach cancer in the People's Hospital of Qianxi County from January 2008 to December 2010 who suffered from associated diarrhea after the chemotherapy treatment were analyzed retrospectively.All patients were given posi tive treatment and nursing intervention,and the cartesian behavior state of patients were evaluated before and after treatment.Results All patients were rescued successfully in this study.Cartesian behavior state score of patients im proved significantly after treatment,there were significant differences compared with before treatment(P 0.05).After active treatment and nursing,138 patients were completely stop diarrhea and avoid the complications.Conclusion Taken by patients with chemotherapy-related diarrhea the targeted active treatment and care interventions to improve the therapeutic effect and quality of life in patients with chemotherapy-induced diarrhea.The effect is obvious.
出处 《中国医药导报》 CAS 2013年第15期157-158,161,共3页 China Medical Herald
基金 河北省唐山市计划项目(编号111302074a)
关键词 化疗相关性腹泻 治疗 护理 评估 Chemotherapy associated diarrhea Treatment Care Assessment
  • 相关文献

参考文献4

二级参考文献27

  • 1Sadahiro S,Suzuki T, Ishikawa K, et al. Recurrence patterns after curative resection of colorectal cancer in patients followed for a minimum of ten years [ J ]. Hepatogastroenterology, 2003,50 ( 53 ) : 1362-1366.
  • 2Kemeny N. Presurgical chemotherapy in patients being considered for liver resection [ J ]. The Oncolologist, 2007, 12 (7) : 825-839.
  • 3Alberts SR, Horvath WL, Sternfeld WC, et al. Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treatment Group phase II study [J].J Clin Oncol, 2005,23 ( 36 ) :9243-9249.
  • 4Santini D,Vincenzi B,Schiavon G, et al. Chronomodulated administration of oxaliplatin plus capetabine ( XELOX ) as first line chemotherapy in advanced colorectal cancer patients: phase U study [ J]. Cancer Chemother Pharmacol, 2007,59 ( 5 ) :613-20.
  • 5Benoist S,Brouquet A, Penna C, et al. Complete response of colorectal liver metastases after chemotherapy: dose it mean cure? [ J ]. J Clin Oncol,2006,24 (24) :3939-3945.
  • 6Elias D, Sideris L, Pocard M, et al. Results of RO resection for colorectal liver metastases associated with extrahepatic disease [ J ]. Ann Surg Oncol,2004,11 ( 3 ) : 274-280.
  • 7Gault DT,Everit AS,Gordon PwN,et al.Serum cholinesterase levels after thermal injury.Is treatment required[J].Bums,1987,13:208~212.
  • 8Palmer KR,Kerr M,Knowles G.Chemotherapy prolongs survival in inoperable pancreatic carcinoma[J].Br J Surg,1994,2:882~885.
  • 9Smith FP,Stablein D,Korsmeyer S.Combination chemotherapy for locally advanced pancreatic cancer:equivalence to external beam irradiation and implication for future management[J].J Clin Oncol,1983,1:413~415.
  • 10Safioleas MC,Moulakakis KG.Pancreatic cancer today[J].Hepatogastroenterology,2004,51:862~868.

共引文献125

同被引文献76

  • 1徐丽春.对进行化疗的胃癌患者实施综合性护理的效果观察[J].当代医药论丛,2014,12(8):71-72. 被引量:3
  • 2李秋萍,李红梅.癌症患者的信息知情情况和抑郁程度的调查[J].解放军护理杂志,2006,23(9):39-41. 被引量:23
  • 3齐敏,董丽,丁凤荣.胃癌患者化疗期间不良反应的观察及对策[J].中国实用护理杂志(中旬版),2007,23(2):46-46. 被引量:9
  • 4金玉彬,刘虹泽,刘闫.心理干预治疗对胃癌患者化疗后心理状态影响的临床观察[J].实用肿瘤学杂志,2007,21(4):397-399. 被引量:16
  • 5范云.中国临床肿瘤学进展[M].北京:人民卫生出版社,2010:70-74.
  • 6Amarasena IU,Walters JA,Wood-Baker R,et al.Platinum versus non-platinum chemotherapy regimens for small cell lung cancer[J].Cochrane Database Syst Rev,2008(4):CD006849.
  • 7Zatloukal P,Cardenal F,Szczesna A,et al.A multicenter international randomized phaseⅢstudy comparing Cisplatin in combination with Irinotecan or Etoposide in previously untreated small-cell lung cancer patients with extensive disease[J].Ann Oncol,2010,12(9):1810-1816.
  • 8Vinolas N,Molina R,Galán MC,et al.Tumor markers in response monitoring and prognosis of non-small cell lung cancer:preliminary report[J].Anticancer Res,1998,18(1B):631-634.
  • 9Marrelli D,Roviello F,De Stefano A,et al. Risk factors for liver metastases after curative surgical procedures for gastric cancer:A prospective study of 208 patients treated with surgical resection[J]. J Am Coll Surg,2004,198(1):51-58.
  • 10Adelsberger H, Quasthoff S, Grosskreutz J,et al. The che-mothera-peutic oxaliplatin alters voltage -gated Na (+)channel kinetics on rat sensory neurons[J]. Eur J Pharma- col,2000,406(1):25-32.

引证文献7

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部